AZD3355 Dose-escalation Study in Healthy Males

Summary

The aim is to establish the maximal tolerated dose of AZD3355 for the selection of doses in the up-coming studies. This will be done by comparing single and repeated doses of AZD3355 to placebo ("inactive substance"). Safety and tolerability variables will be closely monitored throughout the study.

Timeline

Start

2008-09

Primary completion

2008-12

Completion

2008-12

Drugs

Indications